Table of Contents Table of Contents
Previous Page  136 / 164 Next Page
Information
Show Menu
Previous Page 136 / 164 Next Page
Page Background

Silliker

Chem, Res. Center Crete, IL – Validation of a LC-MS/MS Method for Vitamin K Analysis

Silliker Laboratories, Chemistry Research Center, Date: 1/30/15

30

The values obtained were quite satisfactory and in the range of 1.9-7.3%.

Vitamin K2-4 spike recovery evaluation in the SPIFAN samples was repeated on a second day at a

higher spike levels (6.5-7.5 mcg/100g) and the results are presented in Table 9b.

Table 9b: Vitamin K2-4 Spike recovery in SPIFAN matrices on multiple days, Day 2 data

VITAMIN K2-4

Day 2

Sample Parametrs

Sample

ng/g

spike

amt n/g

(approx)

Obtained

(ng/g)

Expected

(ng/g)

%

Recovery

n

1

Mean

0.0

6.5

8.2

8.2

100.2

3

SD

0.2

0.1

3.4

% RSD

3.0

0.7

3.4

Mean

SD

% RSD

2

Mean

0.0

7.0

7.0

6.9

100.5

3

SD

0.0

0.0

1.1

% RSD

0.7

0.5

1.1

Mean

SD

% RSD

3

Mean

0.0

7.0

7.0

7.1

98.0

3

SD

0.1

0.0

2.1

% RSD

2.1

0.1

2.1

Mean

SD

% RSD

4

Mean

0.0

7.5

7.7

7.4

103.6

3

SD

0.2

0.0

3.7

% RSD

3.1

0.5

3.6

Mean

SD

% RSD

5

Mean

0.0

7.5

7.6

7.7

98.2

3

SD

0.4

0.0

6.0

% RSD

5.9

0.3

6.1

Mean

SD

% RSD

The spike recovery evaluation for vitamin K2-4 on the second day of the trial was performed at a

higher spike levels (6.5-7.5 mcg/100g) and was found to be in the range of 98.0-103.6% and within the

VitK-01 w/SLV

FOR ERP USE ONLY

DO NOT DISTRIBUTE